News

The BluePearl Pet Hospital in Tampa, Florida, is now offering the transcatheter edge-to-edge repair (TEER) procedure for its ...
The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...
Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...
Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...
Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.
After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...
The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...
Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the ...
Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...
The Irvine-based medical device maker today announced that it received CE mark approval for its Sapien M3 mitral replacement ...
Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...
Edwards Lifesciences (EW) announced the company’s Sapien M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...